During the corresponding time, Omniab Inc recorded a revenue increase by 244.24 % year on year, sequentially revenue fell by -7.01 %. While revenue at the Omniab Inc 's corporate clients
Omniab Inc's Comment on Sales, Marketing and Customers
The company provides services to large pharmaceutical and biotechnology firms specializing in antibody development, early-stage biotechnology companies, and academic institutions. It offers flexible deal structures and customizable access to its technology platforms to accommodate partner requirements. Its technology portfolio includes OmniRat, OmniDeep, Omni dAb, OmniHub, OmniUltra, and the xPloration Partner Access Program, which support antibody discovery and development as well as peptide therapeutic applications.
OmniAb Revolutionizes Antibody Engineering with Innovative xPloration PlatformEmeryville, Calif. - OmniAb, Inc. made a significant impact at the 20th Annual PEGS Boston Summit by unvei...
Omniab Inc’s Comment on Sales, Marketing and Customers
The company provides services to large pharmaceutical and biotechnology firms specializing in antibody development, early-stage biotechnology companies, and academic institutions. It offers flexible deal structures and customizable access to its technology platforms to accommodate partner requirements. Its technology portfolio includes OmniRat, OmniDeep, Omni dAb, OmniHub, OmniUltra, and the xPloration Partner Access Program, which support antibody discovery and development as well as peptide therapeutic applications.
Sources:
Omniab Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Omniab Inc’s corporate clients.
For your research, we’ve provided 9 tables on Omniab Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.